Jeffrey S Wagener

Summary

Affiliation: University of Colorado
Country: USA

Publications

  1. ncbi Update on newborn screening for cystic fibrosis
    Jeffrey S Wagener
    University of Colorado Medical School, Department of Pediatrics, Denver, Colorado, USA
    Curr Opin Pulm Med 10:500-4. 2004
  2. ncbi Newborn screening for cystic fibrosis
    Jeffrey S Wagener
    Department of Pediatrics, Pediatric Pulmonary Section, University of Colorado School of Medicine and The Children s Hospital, Denver 80218, USA
    Curr Opin Pediatr 15:309-15. 2003
  3. pmc Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis
    Jeffrey S Wagener
    University of Colorado School of Medicine, Aurora, Colorado, USA
    Pediatr Pulmonol 48:666-73. 2013
  4. pmc Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis
    Scott D Sagel
    Department of Pediatrics, The Children s Hospital and University of Colorado Health Sciences Center, Aurora, CO 80045, USA
    J Pediatr 154:183-8. 2009
  5. ncbi Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis
    Michael W Konstan
    Department of Pediatrics, Rainbow Babies and Children s Hospital and Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA
    J Pediatr 151:134-9, 139.e1. 2007
  6. pmc Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms
    Warren E Regelmann
    Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA
    Pediatr Pulmonol 48:649-57. 2013
  7. ncbi Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function
    Raj Padman
    Department of Pediatrics, Alfred I duPont Hospital for Children, Nemours Children s Clinic, Wilmington, DE 19899, USA
    Pediatrics 119:e531-7. 2007
  8. ncbi Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function
    Clement L Ren
    Department of Pediatrics, University of Rochester, Rochester, New York 14642, USA
    Pediatr Pulmonol 42:513-8. 2007
  9. doi Newborn screening for cystic fibrosis
    Jeffrey S Wagener
    University of Colorado School of Medicine, Aurora, Colorado, USA
    Curr Opin Pediatr 24:329-35. 2012
  10. doi Shifting patterns of inhaled antibiotic use in cystic fibrosis
    Samuel M Moskowitz
    Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington 98195 7740, USA
    Pediatr Pulmonol 43:874-81. 2008

Detail Information

Publications25

  1. ncbi Update on newborn screening for cystic fibrosis
    Jeffrey S Wagener
    University of Colorado Medical School, Department of Pediatrics, Denver, Colorado, USA
    Curr Opin Pulm Med 10:500-4. 2004
    ..In this review we discuss the information during the year leading up to this meeting as well as publications since the meeting...
  2. ncbi Newborn screening for cystic fibrosis
    Jeffrey S Wagener
    Department of Pediatrics, Pediatric Pulmonary Section, University of Colorado School of Medicine and The Children s Hospital, Denver 80218, USA
    Curr Opin Pediatr 15:309-15. 2003
    ..In this review, we examine the many advances in CF newborn screening and early care that were reported during the last few years...
  3. pmc Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis
    Jeffrey S Wagener
    University of Colorado School of Medicine, Aurora, Colorado, USA
    Pediatr Pulmonol 48:666-73. 2013
    ..Patients with cystic fibrosis (CF) experience frequent pulmonary exacerbations (PExs). Clinicians manage these episodes of worsening signs and symptoms in a variety of ways...
  4. pmc Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis
    Scott D Sagel
    Department of Pediatrics, The Children s Hospital and University of Colorado Health Sciences Center, Aurora, CO 80045, USA
    J Pediatr 154:183-8. 2009
    ..To assess the effects of Pseudomonas aeruginosa and Staphylococcus aureus infection on lower airway inflammation and clinical status in young children with cystic fibrosis (CF)...
  5. ncbi Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis
    Michael W Konstan
    Department of Pediatrics, Rainbow Babies and Children s Hospital and Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA
    J Pediatr 151:134-9, 139.e1. 2007
    ..To characterize the rate of decline of forced expiratory volume in 1 second (FEV(1)) in children and adolescents with cystic fibrosis and to identify and compare risk factors associated with FEV(1) decline...
  6. pmc Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms
    Warren E Regelmann
    Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA
    Pediatr Pulmonol 48:649-57. 2013
    ....
  7. ncbi Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function
    Raj Padman
    Department of Pediatrics, Alfred I duPont Hospital for Children, Nemours Children s Clinic, Wilmington, DE 19899, USA
    Pediatrics 119:e531-7. 2007
    ..The aim of this study was to assess whether patterns of care for infants at cystic fibrosis sites with superior average lung function in 6- to 12-year-old children showed any differences from those at the lowest outcome sites...
  8. ncbi Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function
    Clement L Ren
    Department of Pediatrics, University of Rochester, Rochester, New York 14642, USA
    Pediatr Pulmonol 42:513-8. 2007
    ..Similar results were seen in patients >or=18 years old. The results of our study highlight the growing clinical impact of MRSA infections in CF patients...
  9. doi Newborn screening for cystic fibrosis
    Jeffrey S Wagener
    University of Colorado School of Medicine, Aurora, Colorado, USA
    Curr Opin Pediatr 24:329-35. 2012
    ..The rapid expansion of screening has resulted in numerous publications identifying new challenges for healthcare providers. This review provides an overview of these publications and includes ideas on managing these challenges...
  10. doi Shifting patterns of inhaled antibiotic use in cystic fibrosis
    Samuel M Moskowitz
    Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington 98195 7740, USA
    Pediatr Pulmonol 43:874-81. 2008
    ..Our working hypothesis was that a shift from acute to chronic use of inhaled antibiotics has coincided with increased prevalence of use among CF patients...
  11. doi Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis
    Clement L Ren
    Department of Pediatrics, University of Rochester, Rochester, NY, USA
    J Pediatr 153:746-51. 2008
    ....
  12. ncbi Complications associated with symptomatic diagnosis in infants with cystic fibrosis
    Frank J Accurso
    Department of Pediatrics, University of Colorado Health Sciences Center, The Children s Hospital, Denver, Colorado 80218, USA
    J Pediatr 147:S37-41. 2005
    ..To determine the complication and hospitalization rates in children with cystic fibrosis (CF) by mode of diagnosis...
  13. ncbi Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes
    Marci K Sontag
    Department of Preventive Medicine and Biometrics and the Department of Pediatrics, University of Colorado Health Sciences Center, Denver, CO 80218, USA
    J Pediatr 147:S83-8. 2005
    ..To examine immunoreactive trypsinogen (IRT)-based screening for cystic fibrosis (CF) for recall rate, genotype distribution, and "borderline" sweat test results...
  14. doi Decreased total serum coenzyme-Q10 concentrations: a longitudinal study in children with cystic fibrosis
    Theresa A Laguna
    Department of Pediatrics, University of Colorado, Denver, School of Medicine, Aurora, CO, USA
    J Pediatr 153:402-7. 2008
    ..To assess total serum levels of coenzyme Q(10) (Co-Q(10)), an important antioxidant, in children with cystic fibrosis (CF) and to investigate an association between Co-Q(10) level and clinical outcome...
  15. pmc Characterizing aggressiveness and predicting future progression of CF lung disease
    Michael W Konstan
    Department of Pediatrics, Rainbow Babies and Children s Hospital, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA
    J Cyst Fibros 8:S15-9. 2009
    ....
  16. ncbi Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution
    Michael W Konstan
    Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
    Hum Gene Ther 15:1255-69. 2004
    ..In conclusion, compacted DNA nanoparticles can be safely administered to the nares of CF subjects, with evidence of vector gene transfer and partial NPD correction...
  17. ncbi Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis
    Scott D Sagel
    Department of Pediatrics, University of Colorado Health Sciences Center, Denver, USA
    J Pediatr 141:811-7. 2002
    ..To validate a sputum induction technique in cystic fibrosis (CF), we examined the relation between airway inflammation and pulmonary function in children with CF by correlating inflammatory indexes in induced sputum with FEV(1)...
  18. ncbi Late diagnosis defines a unique population of long-term survivors of cystic fibrosis
    David M Rodman
    Center for Genetic Lung Disease, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA
    Am J Respir Crit Care Med 171:621-6. 2005
    ..This is the largest cohort of older patients with CF described to date, and our findings indicate that patients diagnosed as adults differ distinctly from survivors of long-term CF diagnosed as children...
  19. ncbi Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis
    Michael W Konstan
    Department of Pediatrics, Rainbow Babies and Children s Hospital and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
    J Pediatr 142:624-30. 2003
    ..To determine the relation of growth and nutritional status to pulmonary function in young children with cystic fibrosis (CF)...
  20. doi Dornase alfa (Pulmozyme)
    Jeffrey S Wagener
    Department of Pediatrics, University of Colorado School of Medicine and Children s Hospital Colorado, Aurora, Colorado 80045, USA
    Curr Opin Pulm Med 18:609-14. 2012
    ..In addition, dornase alfa is being used to treat other medical conditions. This review covers recent publications and expanding indications...
  21. ncbi Cystic fibrosis: current trends in respiratory care
    Jeffrey S Wagener
    Department of Pediatrics, University of Colorado School of Medicine, The Children s Hospital, Denver, Colorado 80218, USA
    Respir Care 48:234-45; discussion 246-7. 2003
    ..Earlier diagnosis has prevented serious complications through early initiation of preventive therapies such as improved nutrition...
  22. doi Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005
    Donald R VanDevanter
    ICON Clinical Research, San Francisco, California, USA
    Pediatr Pulmonol 43:739-44. 2008
    ..Additionally, changes in these variables over the past decade may provide insight into the improving health of the CF population...
  23. ncbi A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis
    Konstantinos A Papas
    Yasoo Health, Johnson City, TN, USA
    J Cyst Fibros 7:60-7. 2008
    ....
  24. ncbi Impact of pregnancy on women with cystic fibrosis
    Ann H McMullen
    University of Rochester School of Nursing, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Chest 129:706-11. 2006
    ..Concern exists among care providers about the impact of pregnancy on the health of women with CF...
  25. ncbi Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis
    Anthony J Kettle
    Free Radical Research Group, Department of Pathology, Christchurch School of Medicine and Health Sciences, P O Box 4345, Christchurch, New Zealand
    Am J Respir Crit Care Med 170:1317-23. 2004
    ..Also, there must be other sourcesof oxidants because protein carbonyls were not related to either inflammation or infection...